XOMA Corporation (XOMA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Mar, 2026Executive summary
Annual meeting scheduled for May 21, 2026, with virtual participation available to shareholders.
Shareholders are encouraged to review proxy materials online and vote by May 20, 2026.
Voting matters and shareholder proposals
Election of seven director nominees for terms expiring in 2027.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
Approval of amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan.
Approval of the 2026 Employee Stock Purchase Plan.
Advisory vote on executive compensation (say-on-pay).
Board of directors and corporate governance
Seven director nominees listed for election, with board recommending a vote for all.
Partial view of Summaries dataset, powered by Quartr API
Latest events from XOMA Corporation
- All proposals, including merger and reorganization, were approved without shareholder questions.XOMA
EGM 2026 - Acquisition closing set for July 14, 2026, with full preferred stock redemption and CVR distribution.XOMAProxy filing
- Merger proposal offers $39/share plus a litigation-tied CVR; board and major holders support approval.XOMAProxy filing
- All proposals, including director elections and plan approvals, passed unanimously with no questions.XOMAAGM 2026
- Amendment adds HoldCo to the merger, clarifies terms, and outlines key risks and approvals needed.XOMAProxy filing
- FY2025 receipts topped $50M; Q1 2026 net income $4.5M; Ligand merger and portfolio growth drive outlook.XOMAQ1 2026
- Acquisition of XOMA Royalty adds significant royalty assets, accelerates growth, and avoids dilution.XOMAProxy filing
- Ligand to acquire XOMA Royalty for $39/share plus CVR, expanding its royalty portfolio and growth.XOMAProxy filing
- Shareholders will vote on director elections, auditor ratification, equity plans, and executive pay.XOMAProxy filing